As previously reported, Jefferies upgraded QuidelOrtho (QDEL) to Buy from Hold with a $44 price target The Q1 report highlighted improving EBITDA margins and the ability to fully mitigate tariffs, notes the analyst, who says that in the case of QuidelOrtho’s guidance being maintained with no tariff impact that “no news is good news.” Valuation has moved lower and the firm sees early signs of a turnaround under CEO Brian Blaser, the analyst tells investors.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QDEL:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue